Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc., a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that it has received 510(k) clearance for BIASURGE™ Advanced Surgical Solution (“BIASURGE™").

Zach Fleming, Sanara's CEO, stated, “A key part of our surgical market growth strategy is to expand the number of efficacious products we offer that improve outcomes and reduce costs. Commercializing BIASURGE™ is the next step in our execution of this strategy, and receiving our 510(k) clearance is a significant milestone as we advance our efforts. This clearance also highlights the capabilities and dedication of Sanara’s research and development team, Rochal Technologies, which has successfully developed this proprietary technology.”

Source: globenewswire.com